SEC Company Response from Fresh2 Group Ltd (FRES) (CIK 0001786511) — Jan 13, 2020
Fresh2 Group Ltd (FRES) (CIK 0001786511)
Date: Jan. 13, 2020 · CIK: 0001786511 · Accession: 0001193125-20-005825
AI Filing Summary & Sentiment
File numbers found in text: 001-39137, 333-234408
Letter
VIA EDGAR Division of Corporation Finance Washington, D.C. 20549 Re: AnPac Bio-Medical Science Co., Ltd. (CIK No. 0001786511) Registration Statement on Form F-1 (File No: 333-234408) Registration Statement on Form 8-A (File No. 001-39137)
Dear Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on January 8, 2020, in which we requested the acceleration of the effectiveness of the above-captioned Registration Statements to 4:00 p.m., New York City time on January 9, 2020. We hereby formally withdraw our prior request for acceleration of the effective date of the above-captioned Registration Statements.
[Signature page follows]
Very truly yours,
AnPac Bio-Medical Science Co., Ltd.
Show Raw Text
CORRESP 1 filename1.htm Withdrawal of CORRESP January 13, 2020 VIA EDGAR Angela Lumley Rufus Decker Jonathan Burr Brigitte Lippmann Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: AnPac Bio-Medical Science Co., Ltd. (CIK No. 0001786511) Registration Statement on Form F-1 (File No: 333-234408) Registration Statement on Form 8-A (File No. 001-39137) Dear Ladies and Gentlemen: Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on January 8, 2020, in which we requested the acceleration of the effectiveness of the above-captioned Registration Statements to 4:00 p.m., New York City time on January 9, 2020. We hereby formally withdraw our prior request for acceleration of the effective date of the above-captioned Registration Statements. [Signature page follows] 1 Very truly yours, AnPac Bio-Medical Science Co., Ltd. By: /s/ Chris Chang Yu Name: Chris Chang Yu Title: Chairman of the Board of Directors and Chief Executive Officer 2